These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 17314422

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH, Pierer K, Santner BI, Vellimedu SK, Stelzl E, Marth E, Fickert P, Stauber RE.
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [Abstract] [Full Text] [Related]

  • 3. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
    García-Bengoechea M, Basaras M, Barrio J, Arrese E, Montalvo II, Arenas JI, Cisterna R.
    Am J Gastroenterol; 1999 Jul; 94(7):1902-5. PubMed ID: 10406257
    [Abstract] [Full Text] [Related]

  • 4. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T.
    Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235
    [Abstract] [Full Text] [Related]

  • 5. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ, Xie Y, Li ZQ.
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [Abstract] [Full Text] [Related]

  • 6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Nov; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 7. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y.
    J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders.
    Sheng L, Soumillion A, Peerlinck K, Verslype C, Lin L, van Pelt J, Hess G, Vermylen J, Yap SH.
    Thromb Haemost; 1997 May; 77(5):868-72. PubMed ID: 9184394
    [Abstract] [Full Text] [Related]

  • 9. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P.
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M, Olaso V, Córdoba J, Gobernado M, Carrasco D, Berenguer J.
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [Abstract] [Full Text] [Related]

  • 13. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T, Ferenci P, Steindl-Munda P, Gschwantler M, Mueller C, Woegerbauer M.
    Clin Infect Dis; 2004 Dec 15; 39(12):1754-60. PubMed ID: 15578395
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Late spontaneous elimination of HCV-RNA from mononuclear cells derived from peripheral blood in patients with chronic hepatitis C].
    Majda-Stanisławska E, Sidorkiewicz M, Jóźwiak B, Pietrzak A, Brzezińska-Błaszczyk E.
    Przegl Epidemiol; 2006 Dec 15; 60(1):79-85. PubMed ID: 16758743
    [Abstract] [Full Text] [Related]

  • 16. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K, Degertekin H, Yildiz F, Kilinc N.
    J Gastroenterol; 2003 Dec 15; 38(8):796-800. PubMed ID: 14505137
    [Abstract] [Full Text] [Related]

  • 17. Treatment response in HCV related chronic hepatitis.
    Hussain AB, Hussain T, Anwar M, Hussain S, Kazmi Y, Tariq WU, Karamat KA.
    J Coll Physicians Surg Pak; 2004 Aug 15; 14(8):466-9. PubMed ID: 15321035
    [Abstract] [Full Text] [Related]

  • 18. A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.
    Annicchiarico BE, Siciliano M, Avolio AW, Grillo RL, Bombardieri G.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1039-46. PubMed ID: 17439504
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT, Young KC, Yang YJ, Lei HY, Wu HL.
    Hepatology; 1996 May 01; 23(5):977-81. PubMed ID: 8621178
    [Abstract] [Full Text] [Related]

  • 20. Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection.
    Meier V, Bürger E, Mihm S, Saile B, Ramadori G.
    J Med Virol; 2003 Jan 01; 69(1):50-8. PubMed ID: 12436477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.